Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by ChupacabraBuenoon May 15, 2015 1:20pm
185 Views
Post# 23733495

RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-

RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-It's axiomatic that investors don't like uncertainty. No surprise then that the injunction has tempered the initial enthusiasm for the MMPR market. The path to profitability has been prolonged. Even the best MMPR companies (TWD certainly being an exemplar of these) have drifted lower over most longish time periods that you could chart them. Vets, military personal, RCMP, university students, (anyone who's MMJ meds are not paid by them personally) and others will continue to gravitate toward the most legit medical providers. That there is plenty of silver lining here is unquestionable. But that injunction is quite an annoying cloud during a time when these companies are struggling to become profitable. I'm long this market - but not nearly as long as I once was. I'm contemplating going longer again, but with tepid enthusiasm until there is less uncertainty and/or lower losses. That sums up my opinion best. Thanks for asking GG. -GLTA
Bullboard Posts